Scientists have shown that defects in the protein CAPRIN1 are the cause of various neurological impairments.
These new insights were made possible by exome analyses, in which scientists observe which genes are altered in a cell. The team also used the GeneMatcher database — a platform on which researchers and physicians exchange information about mutations in genes and diseases associated with them.
ALSO READ: Cardiovascular diseases are linked with an increased risk of adult ADHD: Study
The research team identified twelve patients who had mutations in the CAPRIN1 gene. In them, only half of the amount of protein was produced. Lisa Pavinato, a doctoral researcher in the team of Professor Dr Alfredo Brusco at the University of Turin and DAAD-scholarship holder with Professor Dr Brunhilde Wirth at the University of Cologne, discovered a connection between the deficient production of the protein and certain neurological impairments. The affected persons all had speech disorders, 82 per cent had ADHD, and 67 per cent were affected by autism spectrum disorders and other neurodevelopmental disorders. The function of CAPRIN1 was confirmed in laboratory experiments with human induced pluripotent stem cells in which the CAPRIN1 gene was switched off using the CRISPR/Cas9 technology, creating the conditions from which the affected individuals suffered. Cells with a CAPRIN1 mutation develop shortened processes and faulty circuits that show reduced electrical activity compared to the healthy neurons without the mutation. In contrast, control neurons without the CAPRIN1 mutation form long processes, developing into complex networks. Furthermore, the team also discovered changes in translation, one of the most important cellular processes for error-free cell formation and function. In fact, due to the faulty translation, the mutant neurons began to degenerate and form clumps after a few days. The results of this research have been published in the article ‘CAPRIN1 haploinsufficiency causes a neurodevelopmental disorder with language impairment, ADHD and ASD’ in Brain.
In the second study, GeneMatcher was used to identify three children from different families with a newly developed point mutation at a specific position of the CAPRIN1 gene: an amino acid exchange from proline to leucine at position 512. All three children show the same symptoms of early-onset movement disorders (ataxia), impaired speech motor skills (dysarthria), memory disorders, and myasthenia. Andrea delle Vedove, a doctoral researcher in the team of Professor Wirth, showed that this specific mutation leads to many protein clumps in neuronal cells similar to other neurodegenerative diseases such as Parkinson’s, Alzheimer’s or ataxia. In addition, the activity of the nerve cells was reduced. The study ‘CAPRIN1P512L causes aberrant protein aggregation and associates with early-onset ataxia’ has appeared in Cellular and Molecular Life Sciences.
‘The new research results are important not only for the affected patients and their families, who often spend years searching for answers to understand the cause of their disease, but also for physicians, who can now make faster and more accurate diagnoses,’ said Professor Dr Brunhilde Wirth, Director of the Institute of Human Genetics at University Hospital Cologne, who led the studies together with national and international teams.
This story has been published from a wire agency feed without modifications to the text.